Studies & Results
MCT-Diabetes has been in active use by specific groups of people with Type 1 and
Type 2 diabetes for several years. Appropriate glucose monitoring in groups of people with Type 1 or Type 2 diabetes provides effective management of blood sugar levels as measured by various parameters including HbA1C (Brigham & Women's Hospital and Harvard Medical School: McMahon et al. 2005; Georgetown University Medical Center: Smith et al. 2004)
Dr. Stephen Clement, an endocrinologist at Georgetown University Hospital,
is using MCT-Diabetes with many of his patients. Dr.
Clement’s patients are followed regularly by a certified diabetes educator,
Cherrel Christian, RN, CDE working with Dr. Clement. The patients are
instructed to transfer their blood glucose readings by directly connecting their
glucose meters to a computer and uploading the data via MCT-Diabetes. The
patients use multiple vendors’ glucose meters, including those by Roche
Diagnostics, TheraSense/Abbott, and LifeScan. Ms. Christian regularly provides
encouragement and information to the patients through the MCT-Diabetes web
application and makes treatment changes as identified by Dr. Clement.
Boston Veteran’s Administration Hospital Study
(conducted by Brigham & Women’s Hospital and Harvard Medical School)
A randomized clinical control trial of MCT-Diabetes was carried out at the Boston
Veterans Administration Hospital with patients that were randomly divided
into one of two groups- usual care, or web-management with MCT-Diabetes.
The study compared HbA1c levels at baseline and after a period of
12 months. Participants receiving web-based care management had a greater
decline in HbA1c when compared to participants in the usual care group.
Download Boston VA Study (PDF)
Patients with diabetes were enrolled in a pilot study of MCT-Diabetes at
Georgetown University Medical Center. Patients collected their blood
glucose readings using Accu-Check® Complete™ blood glucose meters from Roche
Diagnostics, Inc. Patients connected their blood glucose meters to their
personal computers with Internet access to transmit their blood glucose
readings weekly. The glucose readings were transferred securely over the
Internet to a central location where the patients and their care providers had
secure access to the clinical data for review. Graphical and statistical
representations of their glucose readings and laboratory data highlighted areas
of concern and identified patterns in their data. Patients were
automatically notified of lab values and blood glucose readings outside of
identified target ranges. Providers evaluated the patient’s condition in
between scheduled office visits. Thus, areas of concern were identified
before they became serious problems.
Download Georgetown Study (PDF)
Funding was recently received to implement MCT-Diabetes at Native American
communities across the US and within the diabetes and pregnancy group at National
Naval Medical Center in Bethesda, Maryland.. Since the MCT-Diabetes technology has
already been proven in two previous studies, this study examines how
culturally diverse populations respond to the MCT-Diabetes technology and
how the technology can be used within the diabetes and pregnancy group of military
personnel and their dependents.
Download Native American Study (PDF)